WA
CLB icon

Waverly Advisors’s Core Laboratories CLB Stock Holding History

Waverly Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-40
Closed -$4K – 365
2015
Q1 		$4K Hold
40
– – ﹤0.01% 306
2014
Q4 		$5K Hold
40
– – ﹤0.01% 368
2014
Q3 		$6K Hold
40
– – ﹤0.01% 582
2014
Q2 		$7K Hold
40
– – ﹤0.01% 514
2014
Q1 		$8K Hold
40
– – ﹤0.01% 465
2013
Q4 		$8K Buy
+40
New +$7.44K ﹤0.01% 585

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Waverly Advisors's CLB Position: Q2 2015 in Review

Waverly Advisors sold out of Core Laboratories (CLB) in Q2 2015, closing a stake of 40 shares — an estimated $4K sold.

Waverly Advisors first reported a position in CLB in Q4 2013 and held it in 6 quarters. The position peaked at $8K in Q1 2014. 357 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

  • Waverly Advisors reported no remaining Core Laboratories position as of Q2 2015 after selling out during the quarter.
  • Waverly Advisors sold 40 Core Laboratories shares in Q2 2015, an estimated $4K.
  • Waverly Advisors first reported a position in Core Laboratories in Q4 2013 and held it in 6 quarters.
  • Waverly Advisors's Core Laboratories position peaked at $8K in Q1 2014.
  • 357 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Waverly Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.